These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma. Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574 [TBL] [Abstract][Full Text] [Related]
3. Epstein Barr virus associated pediatric nasopharyngeal carcinoma: its correlation with p53 and bcl-2 expression. Preciado MV; Chabay PA; De Matteo EN; Gismondi MI; Rey G; Zubizarreta P Med Pediatr Oncol; 2002 May; 38(5):345-8. PubMed ID: 11979459 [TBL] [Abstract][Full Text] [Related]
4. Nasopharyngeal carcinoma in situ: two cases of an emerging diagnostic entity. Cheung F; Pang SW; Hioe F; Cheung KN; Lee A; Yau TK Cancer; 1998 Sep; 83(6):1069-73. PubMed ID: 9740069 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer. Yip KW; Shi W; Pintilie M; Martin JD; Mocanu JD; Wong D; MacMillan C; Gullane P; O'Sullivan B; Bastianutto C; Liu FF Clin Cancer Res; 2006 Oct; 12(19):5726-32. PubMed ID: 17020977 [TBL] [Abstract][Full Text] [Related]
6. Expression of Etk/Bmx tyrosine kinase in the tumorigenicity of nasopharyngeal epithelium and its relation with EB virus infection and the apoptosis-related protein Bcl-2. Guo L; Guo Y; Xiao S Cancer Lett; 2006 Feb; 232(2):255-61. PubMed ID: 16458122 [TBL] [Abstract][Full Text] [Related]
7. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion. Ho CH; Chen CL; Li WY; Chen CJ Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191 [TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr viral infection in extranodal lymphoma of the head and neck: correlation with prognosis and response to treatment. Bahnassy AA; Zekri AR; Asaad N; El-Houssini S; Khalid HM; Sedky LM; Mokhtar NM Histopathology; 2006 Apr; 48(5):516-28. PubMed ID: 16623777 [TBL] [Abstract][Full Text] [Related]
9. Relationship between EBV infection and expression of cellular proteins c-Myc, Bcl-2, and Bax in gastric carcinomas. Lima MA; Ferreira MV; Barros MA; Pardini MI; Ferrasi AC; Mota RM; Rabenhorst SH Diagn Mol Pathol; 2008 Jun; 17(2):82-9. PubMed ID: 18382371 [TBL] [Abstract][Full Text] [Related]
10. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1. Li X; Liu X; Li CY; Ding Y; Chau D; Li G; Kung HF; Lin MC; Peng Y Int J Oncol; 2006 Sep; 29(3):595-603. PubMed ID: 16865275 [TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-associated lymphoepithelioma-like carcinoma of the esophagus. Chen PC; Pan CC; Hsu WH; Ka HJ; Yang AH Hum Pathol; 2003 Apr; 34(4):407-11. PubMed ID: 12733124 [TBL] [Abstract][Full Text] [Related]
12. Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis. Fan SQ; Ma J; Zhou J; Xiong W; Xiao BY; Zhang WL; Tan C; Li XL; Shen SR; Zhou M; Zhang QH; Ou YJ; Zhuo HD; Fan S; Zhou YH; Li GY Hum Pathol; 2006 May; 37(5):593-605. PubMed ID: 16647958 [TBL] [Abstract][Full Text] [Related]
13. [In situ hybridization in undifferentiated nasopharynx carcinoma in Tunisia. Report of 3 cases]. Baizig Nehla M; Hamouda B; Asma K; Farhat BA; Abderahmen L; Omrane BH; Ahmed el M Tunis Med; 2001 Oct; 79(10):544-7. PubMed ID: 11910697 [TBL] [Abstract][Full Text] [Related]
14. The association of genomic variation of Epstein-Barr virus BamHI F fragment with the proliferation of nasopharyngeal carcinoma. Liu Q; Han A; You S; Yang Q; Liang Y; Dong Y APMIS; 2010 Sep; 118(9):657-64. PubMed ID: 20718717 [TBL] [Abstract][Full Text] [Related]
15. [Interaction between Epstein-Barr virus (EBV) gene expression and antibodies to EBV in nasopharyngeal carcinomas]. Furukawa M; Nagayama I; Murono S; Takeshita H; Nishimura T; Yoshizaki T Rinsho Byori; 1996 Sep; 44(9):832-7. PubMed ID: 8911067 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Epstein-Barr virus genotypes and clinicohistopathological features of nasopharyngeal carcinoma between Guilin, China and Fukuoka, Japan. Zhou Y; Nabeshima K; Koga K; Aoki M; Hayashi H; Hamasaki M; Iwasaki H Oncol Rep; 2008 Jun; 19(6):1413-20. PubMed ID: 18497945 [TBL] [Abstract][Full Text] [Related]
17. Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma. Murono S; Yoshizaki T; Park CS; Furukawa M Histopathology; 1999 May; 34(5):432-8. PubMed ID: 10231418 [TBL] [Abstract][Full Text] [Related]
18. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina. Chabay P; De Matteo E; Merediz A; Preciado MV Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377 [TBL] [Abstract][Full Text] [Related]
19. Localization of Epstein-Barr virus in lymph node metastasis with nasopharyngeal carcinoma. Akao I; Sato Y; Mukai K; Sugano S; Hoshikawa T; Suzuki T; Tsutsumi K Acta Otolaryngol Suppl; 1996; 522():86-8. PubMed ID: 8740817 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic application of Epstein-Barr virus-encoded RNA in situ hybridisation. Loughrey M; Trivett M; Lade S; Murray W; Turner H; Waring P Pathology; 2004 Aug; 36(4):301-8. PubMed ID: 15370127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]